Discovery of novel, orally active ACAT inhibitor, FR-186054, reported by Fujisawa Dec. 15, 1997 No Comments
Site-directed, sustained-release delivery system for estradiol in development at Fujisawa Dec. 12, 1997 No Comments
RSS